Sunday, June 6, 2010

Letter Appeal Sample Examination

Farmaindustria Linked to WHO experts pharmaceutical

Patricia Luna-
BBC

Dozens of countries are trying to terminate contracts with the drug after failing to use all that had been stockpiled Tamiflu.

A report on Friday accusing the Organization World Health Organization (WHO) not to disclose the conflict of interest of at least three of the people who wrote the guidelines that were governed by dozens of governments when it comes to spending billions of dollars on measures against swine flu .
According to the document prepared by the medical journal British Medical Journal (BMJ) and the Office of Investigative Journalism, at least three of the researchers who presented the bulk of the scientific documents underlying the procurement of drugs by Governments had received money from any pharmaceutical companies producing drugs.
The authors say that, had he known that this was the case, governments have been dealing with information and recommendation otherwise.
Iaian Overton, editor in chief of the Office of Investigative Reporting told the BBC that "the pattern (of conduct against a pandemic) were heavily influenced by three annexes that were written by three individuals, teachers Fred Hayden, Arnold Monto and Karl Nicholson, who were or had been shortly before that time getting money from pharmaceutical companies they would be waived for their recommendations. " Tamiflu

listed companies are Roche and GlaxoSmithKline (GSK). Roche had profits of billions of dollars from the sale of Tamiflu to governments that followed the WHO recommendations, while GSK produces some relenza and antiviral.

"When there is conflict?"

"While WHO continues to remain tight and do not reveal who he is advising and conflicts of interest, we feel that this is counterproductive. WHO is under suspicion, because it is believed to be hiding something and this raises questions about whether any of its experts, "said Overton.

EUROPA

also asks questions


The document published today coincides with a separate report submitted to the Council of the European Health Committee which reviews the management of WHO in the swine flu crisis.

The report's author, Paul Flynn, the Committee on matters of family and social health of the UK, says that decisions made by WHO were not transparent enough and created a series of problems.

Among them, wasted large sums of public money, the provocation of unwarranted fear among Europeans, creating health risks through medicines that had not been sufficiently tested before being allowed in procedures performed with all the speed and distortion the priorities of public services across Europe.

But Gregory Hart, a spokesman for WHO, said on BBC World that the organization "calls for expressions of interest to all experts and that was what happened on this occasion. The statements are then evaluated by the head of the committee and the secretariat and they are the ones who check whether these conflicts of interest are really such, if you need more information or if indeed there is conflict is asked to leave the committee. And it did not happen this time ".

" There is a distinction between conflict of interest of a person who speaks and charge for them and the conflicting interests of someone who has a salary of a company, "said Hart , who hinted that one of the criteria taken into account in determining whether the conflict is the percentage of money a person receives a drug in relation to total personal income.

WHO spokesman also accused the British Medical Journal (BMJ) have been "incredibly tight" in the selected information to its report:

"The BMJ talks of three experts on a committee of 20, it is very difficult The votes of three people to overcome a 17. "

"The issue is the payment"
But Deborah Cohen, author of the study and reports editor of BMJ, said that "the question is whether people who have been paid by companies that have made billions of dollars selling these drugs should take the decision and write the manuals of behavior and use of these drugs. "

The question is whether people who have been paid by companies that have made billions of dollars selling these drugs should take the decision and write the manuals of behavior and use of these drugs

Deborah Cohen, publishing of reports


BMJ

"I think it is not acceptable," Cohen concluded.

The report of the BMJ and the Office of Investigative Journalism also puts in his look at the secrecy surrounding the committee took the decision to raise a pandemic of swine flu crisis, changing the existing parameters till then.
The document says that protecting the identity of its members, which is only known to the president, to avoid pressure from the industry, but at least three members mentioned belong to that industry which want to escape pressure.

But WHO spokesman said that "these three members declared fully their interests and their own secret committee determined, knowledge of information, there is no conflict of interest. Once the committee has completed its tasks will be posted all information relating to it. "

While there is this exchange of accusations, doubts about the management of WHO during the crisis of the swine flu influenza multiply Across the globe, with research being carried out in many European countries by independent agencies, authorities and even within the same organization.

Posted by admin at 6:24 AM

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)